NFKB1 and cancer: The other group suggested, rather, that accumulation of the p50 subunit into the nucleus of myeloid cells positively controls MDSC differentiation and function, and its deficiency (as in the p50−/− model) or exclusion from the nucleus impaired MDSC action in a cancer setting [54,55,56].